BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19026629)

  • 1. Clozapine attenuates disruptions in response inhibition and task efficiency induced by repeated phencyclidine administration in the intracranial self-stimulation procedure.
    Amitai N; Semenova S; Markou A
    Eur J Pharmacol; 2009 Jan; 602(1):78-84. PubMed ID: 19026629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.
    Amitai N; Semenova S; Markou A
    Psychopharmacology (Berl); 2007 Sep; 193(4):521-37. PubMed ID: 17497138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment.
    Amitai N; Markou A
    Pharmacol Biochem Behav; 2009 Sep; 93(3):248-57. PubMed ID: 18809428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of acute and chronic intermittent phencyclidine-induced performance deficits in the 5-choice serial reaction time task: influence of clozapine.
    Thomson DM; McVie A; Morris BJ; Pratt JA
    Psychopharmacology (Berl); 2011 Feb; 213(4):681-95. PubMed ID: 20878519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of the attenuation effect of repeated antipsychotic treatment on prepulse inhibition disruption induced by repeated phencyclidine treatment.
    Li M; He E; Volf N
    Pharmacol Biochem Behav; 2011 Jun; 98(4):559-69. PubMed ID: 21402097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic.
    Abekawa T; Ito K; Koyama T
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Jun; 375(4):261-71. PubMed ID: 17458542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
    Arvanov VL; Wang RY
    J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.
    Idris NF; Repeto P; Neill JC; Large CH
    Psychopharmacology (Berl); 2005 May; 179(2):336-48. PubMed ID: 15645224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.
    Linn GS; Negi SS; Gerum SV; Javitt DC
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):234-9. PubMed ID: 12845408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats.
    Amitai N; Kuczenski R; Behrens MM; Markou A
    Neuropharmacology; 2012 Mar; 62(3):1422-31. PubMed ID: 21238466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine.
    Sams-Dodd F
    Neuropsychopharmacology; 1998 Apr; 18(4):293-304. PubMed ID: 9509497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
    Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F
    Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in Wistar rats.
    Schwabe K; Brosda J; Wegener N; Koch M
    Pharmacol Biochem Behav; 2005 Feb; 80(2):213-9. PubMed ID: 15680174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine.
    Kargieman L; Santana N; Mengod G; Celada P; Artigas F
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14843-8. PubMed ID: 17785415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of acute and subchronic clozapine and haloperidol on phencyclidine-induced decreases in voluntary sucrose consumption in rats.
    Turgeon SM; Hulick VC
    Pharmacol Biochem Behav; 2007 Mar; 86(3):524-30. PubMed ID: 17320157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol.
    Hashimoto K; Fujita Y; Shimizu E; Iyo M
    Eur J Pharmacol; 2005 Sep; 519(1-2):114-7. PubMed ID: 16099452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice.
    Wang RY; Liang X
    Neuropsychopharmacology; 1998 Jul; 19(1):74-85. PubMed ID: 9608579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA antagonist and antipsychotic actions in cortico-subcortical circuits.
    Kargieman L; Santana N; Mengod G; Celada P; Artigas F
    Neurotox Res; 2008 Oct; 14(2-3):129-40. PubMed ID: 19073421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Models of aspects of schizophrenia: behavioral sensitization induced by subchronic phencyclidine administration.
    Kalinichev M; Bate ST; Jones DN
    Curr Protoc Pharmacol; 2009 Jun; Chapter 5():Unit 5.54. PubMed ID: 22294400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats.
    McLean SL; Beck JP; Woolley ML; Neill JC
    Behav Brain Res; 2008 May; 189(1):152-8. PubMed ID: 18282619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.